Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LETERMOVIR vs LETROZOLE\RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LETERMOVIR vs LETROZOLE\RIBOCICLIB: Safety Overview

Metric LETERMOVIR LETROZOLE\RIBOCICLIB
Total FAERS Reports 1,416 621
Deaths Reported 252 78
Death Rate 17.8% 12.6%
Hospitalizations 398 80
Average Patient Age 46.6 yrs 64.2 yrs
% Female Patients 42.7% 98.2%
FDA Approval Date Aug 30, 2024 N/A
Manufacturer Merck Sharp & Dohme LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A